The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis
about
Novel Insights into the Roles of Rho Kinase in CancerTargeting Mechanotransduction at the Transcriptional Level: YAP and BRD4 Are Novel Therapeutic Targets for the Reversal of Liver FibrosisFibroblast deletion of ROCK2 attenuates cardiac hypertrophy, fibrosis, and diastolic dysfunctionAdvances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantationIdentification and Verification of Potential Therapeutic Target Genes in Berberine-Treated Zucker Diabetic Fatty Rats through Bioinformatics AnalysisGrowth Differentiation Factor-15-Induced Contractile Activity and Extracellular Matrix Production in Human Trabecular Meshwork Cells.ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1/2-dependent ROCK1 activation.Endoplasmic reticulum stress, a new wrestler, in the pathogenesis of idiopathic pulmonary fibrosis.Emerging role of microRNAs in regulating macrophage activation and polarization in immune response and inflammation.Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications.Kinases as Novel Therapeutic Targets in Asthma and Chronic Obstructive Pulmonary Disease.Role of the Rho GTPase/Rho kinase signaling pathway in pathogenesis and treatment of glaucoma: Bench to bedside research.Rho kinase inhibitors: a patent review (2014 - 2016).MiR-199a/b-5p inhibits hepatocellular carcinoma progression by post-transcriptionally suppressing ROCK1PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosisGenetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.Investigational drugs for idiopathic pulmonary fibrosis.Mechanotransduction Mechanisms in Mitral Valve Physiology and Disease Pathogenesis.Mechanosensing and fibrosis.Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148.Evolving Mechanisms of Vascular Smooth Muscle Contraction Highlight Key Targets in Vascular Disease.ROCK as a therapeutic target for ischemic stroke.Discovery and Preclinical Development of Netarsudil, a Novel Ocular Hypotensive Agent for the Treatment of Glaucoma.Activation of transforming growth factor-β1 by thrombin via integrins αvβ1, αvβ3, and αvβ5 in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.Additive effects of the Rho kinase inhibitor Y-27632 and vardenafil on relaxation of the corpus cavernosum tissue of patients with erectile dysfunction and clinical phosphodiesterase type 5 inhibitor failure.RhoA, Rac1 and Cdc42 differentially regulate aSMA and collagen I expression in mesenchymal stem cells.Image-guided chemotherapy with specifically tuned blood brain barrier permeability in glioma margins.Potential regulatory role of circular RNA in idiopathic pulmonary fibrosis
P2860
Q26771368-2CBFC829-AA86-45CD-AF3E-C7D5AB393083Q28070012-469E84CB-8E1D-4C26-A163-87310AFFF137Q33877795-E9C59A25-631D-4BC4-97E8-E29700C81165Q35586614-84B6C49B-4FBE-45B8-B4CD-C6EEFD176760Q36192941-631F1AA8-1019-4095-B72D-5AE3E2AA0A2DQ37494863-6D82260F-BAA1-4ADA-9B7A-6E1E9F080923Q37684020-0496E256-CD7D-4A45-B3E8-7451102E5259Q37685292-171E93C5-EB29-48B4-A8BC-7D8444E7B46BQ38785708-7C094DC1-010F-43BE-9A0F-E4E63B07B7FAQ38812037-5AC51E1E-0346-4E9A-8B9F-9EC8EACBC891Q38882099-86CF7011-DA42-4089-8DFF-E4B783F141C1Q38946178-18D5C951-33F6-43B0-A599-C6FA5367C0E8Q39065919-247DB35C-1778-4E1B-9246-808140B9258BQ41812357-2B18CBEE-FF28-4A9C-953F-B2082B90B5A7Q42652598-309777EB-8C03-4A37-8E64-38894859CD69Q46125322-77AE49D2-804B-41CD-83F9-AD769D95C03AQ46325791-D0E8CFF6-3642-4F06-9CD9-D843EB7303C8Q47191844-B542CBF7-E655-4EB6-B30B-BEF80800BFAEQ47205718-F8068BBC-90A6-4680-B0BD-1F33E2A08963Q47778947-F6784AA7-FF9F-498B-81C8-8E09D944234FQ49923465-A08F3DEA-5C86-4526-A47D-03F7FDC5710AQ50066730-E3223E5D-DFD7-48D1-BC03-F14CAFCF7B16Q50947105-22375276-8F8A-4DAC-9FC9-0FD4085ECCC8Q51024108-97C7028A-2FD2-4AD8-844D-5A5CD8791888Q51373209-D62170A2-9BA6-404B-9246-7DC1C0127CEFQ52560320-E4A13375-3C2E-4202-8608-323DDE9D7C86Q55365320-DC52462F-5032-4553-989B-1797A20DC0ACQ57070375-701F14CC-A9DC-4B1A-9137-B66CB608BD7E
P2860
The Rho kinases: critical mediators of multiple profibrotic processes and rational targets for new therapies for pulmonary fibrosis
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@ast
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@en
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@nl
type
label
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@ast
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@en
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@nl
prefLabel
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@ast
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@en
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@nl
P2093
P2860
P356
P1476
The Rho kinases: critical medi ...... erapies for pulmonary fibrosis
@en
P2093
A. M. Tager
J. K. Liao
R. S. Knipe
P2860
P304
P356
10.1124/PR.114.009381
P407
P577
2015-01-01T00:00:00Z